MAINSAIL_2A: MAINSAIL, figure 2A

MAINSAIL_2AR Documentation

MAINSAIL, figure 2A

Description

Kaplan-Meier digitized data from MAINSAIL, figure 2A (PMID 25743937). A reported sample size of 1,059 for a primary endpoint of OS in prostate cancer.

Usage

MAINSAIL_2A

Format

A data frame of 1,059 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (lenolidomide, placebo)

Source

Petrylak DP, Vogelzang NJ, Budnik N, et al. Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Oncol 2015; 16: 417–25.

Examples

summary(MAINSAIL_2A)

kmplot(MAINSAIL_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.